Joyce Lee, general manager of Amgen Taiwan, shares her journey of building up the affiliate after only having entered the market three years ago and goes on to offer insights on the island’s unique assets to the company’s operations. Ms. Lee also highlights Amgen’s dedication to Taiwan’s healthcare system by introducing innovative biologics and emerging biosimilar products while encouraging “predict & prevent” as a means to support sustainability in the face of an aging population.
Amgen’s key priority is to broaden the access of our products for the benefit of patients.
